activity
20122021
most citedIntegrating Expert ODEs into Neural ODEs: Pharmacology and Disease Progression

18 citations · 34 across the 6 of their papers we have counts for

collaborators

10 papers

cs.LG202118 cited

Integrating Expert ODEs into Neural ODEs: Pharmacology and Disease Progression

Zhaozhi Qian, William R. Zame, Lucas M. Fleuren +2

Modeling a system's temporal behaviour in reaction to external stimuli is a fundamental problem in many areas. Pure Machine Learning (ML) approaches often fail in the small sample…

cs.LG20212 cited

SDF-Bayes: Cautious Optimism in Safe Dose-Finding Clinical Trials with Drug Combinations and Heterogeneous Patient Groups

Hyun-Suk Lee, Cong Shen, William Zame +2

Phase I clinical trials are designed to test the safety (non-toxicity) of drugs and find the maximum tolerated dose (MTD). This task becomes significantly more challenging when mul…

cs.LG202011 cited

Learning outside the Black-Box: The pursuit of interpretable models

Jonathan Crabbé, Yao Zhang, William Zame +1

Machine Learning has proved its ability to produce accurate models but the deployment of these models outside the machine learning community has been hindered by the difficulties o…

cs.LG20201 cited

AutoCP: Automated Pipelines for Accurate Prediction Intervals

Yao Zhang, William Zame, Mihaela van der Schaar

Successful application of machine learning models to real-world prediction problems, e.g. financial forecasting and personalized medicine, has proved to be challenging, because suc…

stat.ML2020

Robust Recursive Partitioning for Heterogeneous Treatment Effects with Uncertainty Quantification

Hyun-Suk Lee, Yao Zhang, William Zame +3

Subgroup analysis of treatment effects plays an important role in applications from medicine to public policy to recommender systems. It allows physicians (for example) to identify…

stat.ML2018

Adaptive Clinical Trials: Exploiting Sequential Patient Recruitment and Allocation

Onur Atan, William R. Zame, Mihaela van der Schaar

Randomized Controlled Trials (RCTs) are the gold standard for comparing the effectiveness of a new treatment to the current one (the control). Most RCTs allocate the patients to th…